These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 26549227
21. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells. Jiang F, Wang X, Liu Q, Shen J, Li Z, Li Y, Zhang J. Toxicol Lett; 2014 Nov 18; 231(1):55-61. PubMed ID: 25196641 [Abstract] [Full Text] [Related]
29. Hepatitis B virus X protein mutant HBxΔ127 promotes proliferation of hepatoma cells through up-regulating miR-215 targeting PTPRT. Liu F, You X, Chi X, Wang T, Ye L, Niu J, Zhang X. Biochem Biophys Res Commun; 2014 Feb 07; 444(2):128-34. PubMed ID: 24434140 [Abstract] [Full Text] [Related]
30. miR-202 suppresses cell proliferation in human hepatocellular carcinoma by downregulating LRP6 post-transcriptionally. Zhang Y, Zheng D, Xiong Y, Xue C, Chen G, Yan B, Ye Q. FEBS Lett; 2014 May 21; 588(10):1913-20. PubMed ID: 24704686 [Abstract] [Full Text] [Related]
31. MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells. Yang Y, Li M, Chang S, Wang L, Song T, Gao L, Hu L, Li Z, Liu L, Yao J, Huang C. Mol Med Rep; 2014 Nov 21; 10(5):2643-8. PubMed ID: 25174704 [Abstract] [Full Text] [Related]
32. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma. Xue X, Gao W, Sun B, Xu Y, Han B, Wang F, Zhang Y, Sun J, Wei J, Lu Z, Zhu Y, Sato Y, Sekido Y, Miao Y, Kondo Y. Oncogene; 2013 Mar 28; 32(13):1724-34. PubMed ID: 22614011 [Abstract] [Full Text] [Related]
33. [miR-124 suppresses cell proliferation and invasion in gastric carcinoma and its mechanism]. Xie LM, He RF, Zhang ZW, Tang YY, Luo ZY. Zhonghua Zhong Liu Za Zhi; 2013 Jul 28; 35(7):497-500. PubMed ID: 24257299 [Abstract] [Full Text] [Related]
34. MicroRNA-363-mediated downregulation of S1PR1 suppresses the proliferation of hepatocellular carcinoma cells. Zhou P, Huang G, Zhao Y, Zhong D, Xu Z, Zeng Y, Zhang Y, Li S, He F. Cell Signal; 2014 Jun 28; 26(6):1347-54. PubMed ID: 24631531 [Abstract] [Full Text] [Related]
35. Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer. Zhang Y, Wang X, Xu B, Wang B, Wang Z, Liang Y, Zhou J, Hu J, Jiang B. Oncol Rep; 2013 Oct 28; 30(4):1976-84. PubMed ID: 23900443 [Abstract] [Full Text] [Related]
38. miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF. Sun CY, She XM, Qin Y, Chu ZB, Chen L, Ai LS, Zhang L, Hu Y. Carcinogenesis; 2013 Feb 28; 34(2):426-35. PubMed ID: 23104180 [Abstract] [Full Text] [Related]
39. MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway. Yang X, Zhang XF, Lu X, Jia HL, Liang L, Dong QZ, Ye QH, Qin LX. Hepatology; 2014 May 28; 59(5):1874-85. PubMed ID: 24259426 [Abstract] [Full Text] [Related]
40. Inhibition of hepatocellular carcinoma growth and angiogenesis by dual silencing of NET-1 and VEGF. Wu YY, Chen L, Wang GL, Zhang YX, Zhou JM, He S, Qin J, Zhu YY. J Mol Histol; 2013 Aug 28; 44(4):433-45. PubMed ID: 23636606 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]